ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 288 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2021. The put-call ratio across all filers is 0.47 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $657,616 | +45.1% | 24,474 | +92.6% | 0.08% | +2.7% |
| Q2 2023 | $453,239 | -55.6% | 12,710 | -68.4% | 0.08% | -64.8% |
| Q1 2023 | $1,020,470 | +180.3% | 40,176 | +407.5% | 0.21% | +334.7% |
| Q1 2022 | $364,000 | -46.6% | 7,916 | -3.8% | 0.05% | -49.0% |
| Q2 2021 | $682,000 | -40.8% | 8,230 | -45.2% | 0.10% | -63.8% |
| Q1 2021 | $1,153,000 | 0.0% | 15,030 | 0.0% | 0.26% | +1.1% |
| Q4 2020 | $1,153,000 | +76.0% | 15,030 | -1.2% | 0.26% | +84.5% |
| Q3 2020 | $655,000 | +9.0% | 15,211 | -27.2% | 0.14% | -8.4% |
| Q1 2020 | $601,000 | +38.5% | 20,900 | -11.7% | 0.16% | +573.9% |
| Q1 2019 | $434,000 | -79.2% | 23,666 | -78.3% | 0.02% | -81.9% |
| Q3 2018 | $2,089,000 | – | 108,984 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 908,474 | $24,410,696 | 22.12% |
| Western Financial Corp/CA | 820,239 | $22,039,822 | 16.16% |
| JOHNSON & JOHNSON | 247,598 | $6,652,958 | 2.45% |
| WEALTH EFFECTS LLC | 164,750 | $4,426,835 | 2.19% |
| M28 Capital Management LP | 67,400 | $1,811,038 | 2.08% |
| Privium Fund Management B.V. | 259,036 | $6,960,298 | 2.07% |
| Evolutionary Tree Capital Management, LLC | 51,266 | $1,377,517 | 1.78% |
| Avidity Partners Management LP | 1,063,897 | $28,586,912 | 1.15% |
| SECTORAL ASSET MANAGEMENT INC | 157,552 | $4,233,422 | 0.82% |
| Vivo Capital, LLC | 137,411 | $3,692,234 | 0.40% |